Featured Research

from universities, journals, and other organizations

Parents experience difficulty with consent process in pediatric cancer trials, study suggests

Date:
October 25, 2010
Source:
Dana-Farber Cancer Institute
Summary:
Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a new study.

Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.

Related Articles


Parents who had agreed to their children's enrollment in treatment trials said they felt hurried in making the decision, the researchers said. They also perceived themselves as less well-informed about the clinical trial protocols than did adult patients, even though tests showed they understood the issues equally well.

"These findings were consistent with what we suspected, given the different contexts in which adult and pediatric clinical trials are offered," said Steven Joffe, MD, MPH, senior author of the study. "But I didn't expect such large differences."

The researchers administered questionnaires to 47 parents and 204 trial participants within two weeks after the clinical study began.

Results showed that only 64 percent of parents felt they had enough time to learn about the trial, compared to 87 percent of adults. The parents were also less likely (79 percent to 93 percent) to report that they had sufficient opportunity to ask questions.

Even though they scored about the same on objective tests about the trials' particulars, parents of children with cancer rated themselves as less knowledgeable (79.5 percent) than did adult patients (87.8 percent).

Joffe, an ethicist and pediatric hematologist/oncologist at Dana-Farber/Children's Hospital Cancer Center, attributed much of the disparity to the differing contexts in which adults and pediatric patients are offered clinical trial participation.

"The adult patients tended to have solid tumors and had lived with their disease for a long time. Most of the adult patients were offered a trial because they had relapsed or their disease had progressed," he noted.

"For these patients, there wasn't as much urgency in getting started on a protocol, and they had moved beyond the initial crisis of learning that they had cancer."

Conversely, about three-quarters of the pediatric patients were facing a new diagnosis of cancer -- usually a blood malignancy like leukemia.

"Often they were in the hospital and their parents had known about the diagnosis only for a day or two, and they had to make urgent decisions at a time of tremendous shock and emotional upheaval," Joffe said. "The parents were often overwhelmed and it made them feel less certain they understood the information they were given about the trial."

Joffe said the study confirms concerns that have already prompted efforts to alleviate the confusion surrounding decisions made in the middle of an emotional crisis. For example, some medical personnel now make a return visit to patients or parents "after the initial storm has passed" to make sure they have understood the protocol correctly.

Also, clinical researchers, in some cases, are relieving clinical study recruits of the necessity to make decisions on all aspects of a trial right away, he said. "Often there are randomizations to one treatment or another that occur later in the overall trial, and we are delaying the consent process for those aspects rather than asking people to make all those decisions on Day One."

The abstract is being presented at SIOP by first author Tony Truong, MD, of the Hospital for Sick Children in Toronto. Other authors are E. Francis Cook, ScD, of the Harvard School of Public Health and Jane Weeks, MD, of Dana-Farber.


Story Source:

The above story is based on materials provided by Dana-Farber Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Dana-Farber Cancer Institute. "Parents experience difficulty with consent process in pediatric cancer trials, study suggests." ScienceDaily. ScienceDaily, 25 October 2010. <www.sciencedaily.com/releases/2010/10/101022111832.htm>.
Dana-Farber Cancer Institute. (2010, October 25). Parents experience difficulty with consent process in pediatric cancer trials, study suggests. ScienceDaily. Retrieved January 30, 2015 from www.sciencedaily.com/releases/2010/10/101022111832.htm
Dana-Farber Cancer Institute. "Parents experience difficulty with consent process in pediatric cancer trials, study suggests." ScienceDaily. www.sciencedaily.com/releases/2010/10/101022111832.htm (accessed January 30, 2015).

Share This


More From ScienceDaily



More Science & Society News

Friday, January 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Obama To Outline New Plan For Personalized Medicine

Obama To Outline New Plan For Personalized Medicine

Newsy (Jan. 30, 2015) President Obama is expected to speak with drugmakers Friday about his Precision Medicine Initiative first introduced last week. Video provided by Newsy
Powered by NewsLook.com
Oxfam Calls for Massive Aid for Ebola-Hit West Africa

Oxfam Calls for Massive Aid for Ebola-Hit West Africa

AFP (Jan. 29, 2015) Oxfam International has called for a multi-million dollar post-Ebola "Marshall Plan", with financial support given by wealthy countries, to help Guinea, Sierra Leone and Liberia to recover. Duration: 01:10 Video provided by AFP
Powered by NewsLook.com
Tesla 'Insane Mode' Gives Unsuspecting Passengers the Ride of Their Life

Tesla 'Insane Mode' Gives Unsuspecting Passengers the Ride of Their Life

RightThisMinute (Jan. 29, 2015) If your car has an "Insane Mode" then you know it&apos;s fast. Well, these unsuspecting passengers were in for one insane ride when they hit the button. Tesla cars are awesome. Video provided by RightThisMinute
Powered by NewsLook.com
Now Bill Gates Is 'Concerned' About Artificial Intelligence

Now Bill Gates Is 'Concerned' About Artificial Intelligence

Newsy (Jan. 29, 2015) Bill Gates joins the list of tech moguls scared of super-intelligent machines. He says more people should be concerned, but why? Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Science & Society

Business & Industry

Education & Learning

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins